✉news HealthMedicine first seen 10 h ago, last 5 h ago, peak #14

WhiteLab Genomics raises $26m for AI-designed genomic medicines

Original: WhiteLab Genomics raises $26m to advance AI-designed genomic medicines

WhiteLab Genomics has raised $26 million to advance its work on AI-designed genomic medicines. The Paris-based biotech uses artificial intelligence to speed up the design of gene and cell therapies, and the fresh funding will support development of its computational platform and drug pipeline. Observers see the deal as further proof that investors remain keen on AI applied to drug discovery.

Why now: AI-driven drug discovery funding is attracting attention as biotech investors bet on computational platforms to cut development timelines.

WhiteLab GenomicsDrug Target Review

Open on news →

Rank over time, top of the chart is #1. 5 snapshots from 10 h ago to 5 h ago.

Evidence

• WhiteLab Genomics raises $26m to advance AI-designed genomic medicines · Drug Target Review

API: https://socialmediatrends-api.osmike.com/v1/trends/1473228